advisorsecurities master

DRTSAlpha Tau Medical Ltd. Ordinary Shares

CSNasdaq (XNAS)·USD

Identity

Security key
14396
Ticker
DRTS
Type
CSCommon Stock
Exchange
Nasdaq(XNAS)
Venue group
NASDAQ
Operating MIC
XNAS
Market
stocks
Locale
us
Currency
USD
Listed
2022-03-08
Round lot
100
Active
Yes
Last seen in a load
2026-08-14 20:49
Vendor updated
2026-08-13 06:09
Ticker root / suffix
DRTS

Detail

Enriched 2026-08-14 20:47

Market cap
$1,252,819,900.12
Shares outstanding (class)
90,325,876
Shares outstanding (weighted)
90,325,876
SIC
Employees
121
Location
Description

Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as a localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company has active clinical programs targeting a range of different tumor types, such as head and neck cancer, pancreatic cancer, brain cancer, liver metastases, lung cancer, and prostate cancer. Geographically, it operates in Israel, United States, and Japan with the majority of the revenue generated from Israel.

Market cap and share counts drift.

Funds holding this security

Identifiers

Classification

Fund data